1 Takahashi H,Inamori M.Life style-related disease and colorectal cancer[J].Intern Med,2009,48(3):121. 2 Song Y,Liu M,Yang FG,et al.Dietary fibre and the risk of colorectal cancer:a case-control study[J].Asian Pac J Cancer Prev,2015,16(9):3747-3752. 3 Shivappa N,Zucchetto A,Montella M,et al.Inflammatory potential of diet and risk of colorectal cancer:a case-control study from Italy[J].Br J Nutr,2015,114(1):152-158. 4 Miki J,Furusato B,Li H,et al.Identification of putative stem cell markers,CD133 and CXCR4,in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens[J].Cancer Res,2007,67(7):3153-3161. 5 Lin SH,Liu T,Ming X,et al.Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions[J].Sci Rep,2016,6(16):21184-21194. 6 Sui YP,Jian XP,Ma LI,et al.Prognostic value of cancer stem cell marker CD133 expression in esophageal carcinoma:A meta-analysis[J].Mol Clin Oncol,2016,4(1):77-82. 7 O′Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J].Nature,2007,445(7123):106-110. 8 Singh-Ranger G,Giordano P.A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer[J].Int J Colorectal Dis,2009,24(7):863-863. 9 Tabriz HM,Mirzaalizadeh M,Gooran S,et al.COX-2 expression in renal cell carcinoma and correlations with tumor grade,stage and patient prognosis[J].Asian Pac J Cancer Prev,2016,17(2):535-538. 10 El-Gamal EM,Gouida MS.Flow cytometric study of cell cycle and DNA ploidy in bilharzial bladder cancer[J].Clin Lab,2015,61(3-4):211-218. 11 Staarmann J,Kotb WF,Petersen I.DNA ploidy and morphology of colon tumors in the adenoma-carcinoma sequence[J].Folia Histochem Cytobiol,2015,53(1):11-18. 12 Yang ZL,Zheng Q,Yan J,et al.Upregulated CD133 expression in tumorigenesis of colon cancer cells[J].World J Gastroenterol,2011,17(7):932-937. 13 Ricci-Vitiani L,Lombardi DG,Pilozzi E,et al.Identification and expansion of human colon-cancer-initiating cells[J].Nature,2007,445(7123):111-115. 14 Li CY,Li BX,Liang Y,et al.Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage ⅢB[J].J Transl Med,2009,7(7):56-63. 15 Feng HL,Liu YQ,Yang LJ,et al.Expression of CD133 correlates with differentiation of human colon cancer cells[J].Cancer Biol Ther,2010,9(3):216-223. 16 Saigusa S,Tanaka K,Toiyama Y,et al.Immunohistochemical features of CD133 expression:association with resistance to chemoradiotherapy in rectal cancer[J].Oncol Rep,2010,24(2):345-350. 17 Fawzy MS,Elfayoumi AR,Mohamed RH,et al.Cyclooxygenase 2(rs2745557)polymorphism and the susceptibility to benign prostate hyperplasia and prostate cancer in egyptians[J].Biochem Genet,2016,54(3):1-11. 18 Tuynman JB,Peppelenbosch MP,Richel DJ.COX-2 inhibition as a tool to treat and prevent colorectal cancer[J].Crit Rev Oncol Hematol,2004,52(2):81-101. 19 Yang H,Yin P,Shi Z,et al.Sinomenine,a COX-2 inhibitor,induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo[J].Oncol Lett,2016,11(1):411-418. 20 Zhan J,Liu JP,Zhu ZH,et al.Relationship between COX-2 expression and clinicopathological features of colorectal cancers[J].Chin Med J(Engl),2004,117(8):1151-1154. 21 Heasley LE,Han SY.JNK regulation of oncogenesis[J].Mol Cells,2006,21(2):167-173. 22 Fan X,Matsui W,Khaki L,et al.Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors[J].Cancer Res,2006,66(15):7445-7452. 23 Zhang X,Gaspard JP,Chung DC.Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia[J].Cancer Res,2001,61(16):6050-6054. |